Effects of Patient-centered Stroke Educating System: a Randomized Controlled Trial

Overview

The aim of this study is to establish PAtient-Centered Computerized Educating System for Stroke (PACCESS) for patients with different demands and lack of knowledge.Those in the intervention group will receive the PACCESS and the control groups will receive traditional health education to test the effects of PACCESS in increasing clinical decision-making, health behavior, activities of daily living and knowledge of stroke, and health care quality.

Full Title of Study: “Effects of Health-education Application on Improving Stroke-related Knowledge and Health Related Quality of Life in Patients With Stroke: a Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: Single (Investigator)
  • Study Primary Completion Date: October 2016

Detailed Description

To prevent recurrent stroke and improve the health-related quality of life (HRQOL) in patients with stroke, education regarding the risk factors of recurrent stroke is a crucial part of effective care for patients with stroke. The aim of this study was to develop an application capable of providing health education for recurrent-stroke prevention. We also examined the effectiveness of this app for improving stroke-related knowledge and HRQOL in patients with stroke.

Interventions

  • Device: smart phone and pad
    • Smart phone and pad is the mobile include the smart phone and pad, that can download the APP from internet.
  • Other: stroke-related health education manual
    • stroke-related health education manual is the manual mainly contained information regarding the prevention of stroke risk factors.

Arms, Groups and Cohorts

  • Experimental: health-education app
    • Smart phone and pad is a stroke-related health education app intervention group
  • Active Comparator: health education manuals
    • stroke-related health education manual control group

Clinical Trial Outcome Measures

Primary Measures

  • Stroke Health Education Knowledge Questionnaire
    • Time Frame: 4 weeks
    • The stroke knowledge questionnaire is the primary outcome of this study. The questions are single-choice questions. The content of the questions are based on the stroke health education manual and adapted to APP format in this study. For the 12 risk factors, each risk factor was sorted out 3 questions. There are total of 36 (3×12 = 36) questions of stroke knowledge, a score of 1 for each question, the highest score of 3 for each risk factor, the highest score of 36 points and the lowest score of 0 point. The higher score represents the better outcome.

Participating in This Clinical Trial

Inclusion Criteria

  • first time diagnosis of stroke (International Classification of Diseases, ninth revision, clinical modification [ICD-9] codes) of cerebral hemorrhage (ICD-9, 431) or cerebral infarction (ICD 9, 434)
  • ability to follow instructions and complete the interviews
  • having a designated caregiver who agrees to participate in the survey
  • >6 years of education
  • have smartphone or the other mobile device can download the APP from internet.

Exclusion Criteria

  • cognitive impairment (Mini-Mental State Examination (MMSE scores<24)
  • having major mental diseases (i.e., depression, dementia, delirium, etc.)
  • the inability to read/answer questionnaires

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Taipei Medical University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Wen-Hsuan Hou, PHD, Study Chair, Taipei Medical University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.